Brand Post September 20, 2024 Wright, Moore, DeHart, Dupuis & Hutchinson Provides Notice of Data Security Incident LAFAYETTE, La., Sept. 19, 2024 /PRNewswire/ -- Wright, Moore, DeHart, Dupuis & Hutchinson ("WMDDH") has become aware of a data security…
Brand Post September 20, 2024 SUN VALLEY GOLD LLC: DISPOSITION OF COMMON SHARES OF AMARC RESOURCES LTD. SUN VALLEY, Idaho, Sept. 19, 2024 /CNW/ - Sun Valley Gold LLC ("Sun Valley") announced today that it has disposed of…
Brand Post September 20, 2024 GEEKOM releases a perfect mini PCs with dual 2.5Gbps Ethernet ports – GEEKOM GT1 MEGA TAIPEI, Sept. 19, 2024 /PRNewswire/ -- GEEKOM, a Taiwanese tech company also known as the Green Mini PC Global Leader,…
Brand Post September 20, 2024 Ultima Markets Wins Two Prestigious Awards at Global Forex Awards–Retail 2024! LIMASSOL, Cyprus, Sept. 19, 2024 /PRNewswire/ -- Ultima Markets, a leading global forex and CFDs brokerage, is thrilled to announce its…
Brand Post September 20, 2024 Gen.G Esports Announces Partnership with Descente to Launch the Worlds 2024 Uniform Gen.G unveils Descente collaboration uniform, reflecting their belief in winning Worlds SEOUL, South Korea, Sept. 19, 2024 /PRNewswire/ -- Global…
Brand Post September 19, 2024 Trinity Capital Inc. Increases its Credit Facility to $510 Million PHOENIX, Sept. 19, 2024 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity" or the "Company"), a leading provider of diversified…
Brand Post September 19, 2024 FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER HIGHLIGHTS The US FDA has granted Fast Track Designation to Amplia's lead drug narmafotinib in advanced pancreatic cancerFast Track Designation…
Brand Post September 19, 2024 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, FYBR, GATO, SGRP on Behalf of Shareholders NEW YORK, Sept. 19, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies…
Brand Post September 19, 2024 RYBREVANT® (amivantamab-vmjw) plus standard of care approved in the U.S. as first and only targeted regimen to cut risk of disease progression by more than half in second-line EGFR-mutated advanced lung cancer Approval based on compelling safety and efficacy from the Phase 3 MARIPOSA-2 study, marking the third new indication for RYBREVANT®…
Brand Post September 19, 2024 NASA Sets Coverage for Astronaut Tracy C. Dyson, Crewmates Return WASHINGTON, Sept. 19, 2024 /PRNewswire/ -- NASA astronaut Tracy C. Dyson, accompanied by Roscosmos cosmonauts Nikolai Chub and Oleg Kononenko, will…
Brand Post September 19, 2024 Mānuka: The hottest super-ingredient powering a skincare revolution LOS ANGELES, Sept. 19, 2024 /PRNewswire/ -- Get ready, Los Angeles! Launching soon, MN8 is shaking up skincare with a groundbreaking…
Brand Post September 19, 2024 Illinois Bone & Joint Institute, LLC Data Breach Alert: Issued by Wolf Haldenstein Adler Freeman & Herz LLP NEW YORK and CHICAGO, Sept. 19, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP, a preeminent national consumer rights law…